Answers are grounded in this paper and cite their sources.
Supplementary Figure S6. Metabolomics of Wilms tumors were used to determine differential abundance of metabolites, expressed as log2-fold-change in tumors with microRNA processing mutations versus without such mutations, demonstrating that the antioxidant BH₄ is depleted in tumors with microRNA processing mutations.
No takes yet. Share an insight, caveat, or question.
Tiburcio et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: